dr. T. van Meerten

Faculty of Medical Sciences

Telephone:

+31 50 361 2354

E-mail:

t.van.meerten umcg.nl

Research Portal

Publications

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis

WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, 6-Jul-2021 , (E-pub ahead of print) In: JAMA. 20 p.

Research output: Contribution to journal › Article › Academic › peer-review

Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment

van Doesum, J. A. , Niezink, A. G. H. , Huls, G. A. , Beijert, M. , Diepstra, A. & van Meerten, T. , Feb-2021 , In: HemaSphere. 5 , 2 , 9 p. , 523.

Research output: Contribution to journal › Review article › peer-review

Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands

van Doesum, J. , Chinea, A., Pagliaro, M., Pasquini, M. C., van Meerten, T. , Bakker, M. & Ammatuna, E. , Sep-2020 , In: Leukemia. 34 , 9 , p. 2536-2538 3 p.

Research output: Contribution to journal › Letter › Academic › peer-review

Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield

de Jesus, F. M. M. , Kwee, T. C. , Kahle, X. U. , Nijland, M. , van Meerten, T. , Huls, G. , Dierckx, R. A. J. O. , Rosati, S. , Diepstra, A. , van der Bij, W. , Verschuuren, E. A. M. , Glaudemans, A. W. J. M. & Noordzij, W. , Mar-2020 , In: European Journal of Nuclear Medicine and Molecular Imaging. 47 , 3 , p. 529-536 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Interim thymus and activation regulated chemokine versus interim F-18-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation

Plattel, W. J. , Visser, L. , Diepstra, A. , Glaudemans, A. W. J. M. , Nijland, M. , van Meerten, T. , Kluin-Nelemans, H. C. , van Imhoff, G. W. & van den Berg, A. , 27-Feb-2020 , In: British Journal of Haematology. 190 , 1 , p. 40-44 5 p.

Research output: Contribution to journal › Article › Academic › peer-review

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

Morello, L., Rattotti, S., Giordano, L., Jerkeman, M., van Meerten, T. , Krawczyk, K., Moita, F., Marino, D., Ferrero, S., Szymczyk, M., Aurer, I., El-Galaly, T. C., Di Rocco, A., Visco, C., Carli, G., Defrancesco, I., Carlo-Stella, C., Dreyling, M., Santoro, A. & Arcaini, L., Feb-2020 , In: HemaSphere. 4 , 1 , 6 p. , 302.

Research output: Contribution to journal › Article › Academic › peer-review

Molecular imaging in lymphoma beyond F-18-FDG-PET: understanding the biology and its implications for diagnostics and therapy

Kahle, X. U. , de Jesus, F. M. M. , Glaudemans, A. W. J. M. , Lub-de Hooge, M. N. , Jorritsma-Smit, A. , Plattel, W. J. , van Meerten, T. , Diepstra, A. , van den Berg, A. , Kwee, T. C. , Noordzij, W. , de Vries, E. G. E. & Nijland, M. , Jun-2020 , In: Lancet Haematology. 7 , 6 , p. E479-E489 11 p.

Research output: Contribution to journal › Review article › peer-review

WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma

de Jong, M. R. W. , Langendonk, M. , Reitsma, B., Herbers, P., Lodewijk, M., Nijland, M. , van den Berg, A. , Ammatuna, E. , Visser, L. & van Meerten, T. , Jan-2020 , In: Therapeutic advances in hematology. 11 , p. 2040620719898373 14 p. , 2040620719898373.

Research output: Contribution to journal › Article › Academic › peer-review

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

He, Y., Bouwstra, R. , Wiersma, V. R. , de Jong, M. , Lourens, H. J., Fehrmann, R. , de Bruyn, M. , Ammatuna, E. , Huls, G. , van Meerten, T. & Bremer, E. , 1-Feb-2019 , In: Nature Communications. 10 , 1 , 8 p. , 533.

Research output: Contribution to journal › Article › Academic › peer-review

CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Bouwstra, R. , He, Y., de Boer, J. W., Kooistra, H. , Cendrowicz, E. , Fehrmann, R. S. N. , Ammatuna, E. , Eulenburg, C., Nijland, M. , Huls, G. , Bremer, E. & van Meerten, T. , Oct-2019 , In: Cancer immunology research. 7 , 10 , p. 1663-1671 9 p.

Research output: Contribution to journal › Article › Academic › peer-review